Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical

Ji Yih Chen1, Yee Ling Wu2, Mo Yin Mok3

  • 1Department of Medicine, Division of Allergy, Immunology and Rheumatology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan, Republic of China.

Insights

Copy number variations in complement C4 (C4) influence systemic lupus erythematosus (SLE) risk. High C4 gene copy numbers protect against SLE in East Asians, while C4A deficiency is a significant risk factor, differing in genetic basis between ethnic groups.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Human Genetics

Background:

  • Human complement C4 (C4) exhibits complex diversity with multiple layers of variation.
  • Understanding C4 copy number variations (CNVs) and their association with disease risk, particularly in systemic lupus erythematosus (SLE), is crucial.
  • Investigating racial differences in C4A deficiency mechanisms can provide insights into SLE pathogenesis.

Purpose of the Study:

  • To elucidate the role of C4A and C4B copy number variations (CNVs) in systemic lupus erythematosus (SLE) risk.
  • To compare the genetic basis of C4A deficiency between East Asian and European populations.
  • To identify genetic factors contributing to C4 deficiency and its clinical manifestations.

Main Methods:

  • Genotyping technologies were employed to determine gene copy numbers (GCNs) of total C4, C4A, and C4B in 999 SLE patients and 1,347 healthy East Asian subjects.
  • Analysis included variations in C4-Long and C4-Short genes, and investigation of genomic regions with C4B96.
  • Comparison of C4 CNV and deficiency patterns with European populations, including HLA linkage analysis.

Main Results:

  • High GCNs of total C4 and C4A demonstrated a protective effect against SLE in East Asians; low/medium GCNs and absence of C4-Short genes were risk factors.
  • Homozygous C4A deficiency, though infrequent, significantly increased SLE susceptibility (OR 12.4). Low serum complement levels correlated with low C4 GCNs and were associated with anti-dsDNA antibodies, hemolytic anemia, and renal disease.
  • Distinct C4 haplotypes underlie C4A deficiency in East Asians (recombinant, bimodular C4-Long/C4-Short, linked to HLA-DRB1*1501) compared to Europeans (monomodular-Short, linked to HLA-DRB1*0301), with C4B96 showing an E920K polymorphism.

Conclusions:

  • C4 CNVs and C4A deficiency are significant contributors to SLE risk and disease manifestations in both East Asian and European populations.
  • Genetic variations in C4 influence susceptibility to SLE and its associated clinical features.
  • Understanding these genetic underpinnings is vital for comprehending SLE pathogenesis across diverse ethnic groups.
Abstract

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.2K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.0K
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
12.4K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.6K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.8K